EIF4EBP1 and nasopharyngeal carcinoma: Chen and colleagues reported that the 5-year OS rate in patients with high LMP1 expression (n = 141) was 54%, and with low LMP1 expression (n = 83) was 68% (P = 0.020); the 5-year OS rate for NPC patients with high p-P70S6K expression (n = 106) was 49%, and low p-P70S6K expression (n = 118) was 69% (P = 0.049); the 5-year OS rate in patients with high p-4EBP1 expression (n = 128) was 49%, and low p-4EBP1 expression (n = 95) was 71% (P = 0.010).